Skip to content

Clinical trials

Phase 3 Intellectual Disability trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Intellectual Disability Phase: Phase 3 Country / region: United States Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20232
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting3
Unknown status3
Completed2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)4
Taysha Gene Therapies, Inc.2
Neurogene Inc.1
Shionogi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Intellectual Disability8
Neurologic Manifestations4
Genetic Diseases, X-Linked3
Nervous System Diseases3
Neurodevelopmental Disorders3
Pathologic Processes3
Rett Syndrome3
Cerebral Palsy2
Congenital, Hereditary, and Neonatal Diseases and Abnormalities2
X-Linked Intellectual Disability2

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.